Logos Global Management as of Dec. 31, 2019
Portfolio Holdings for Logos Global Management
Logos Global Management holds 38 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 21.1 | $86M | 664k | 128.86 | |
| Sarepta Therapeutics (SRPT) | 7.2 | $29M | 226k | 129.04 | |
| Ascendis Pharma A S (ASND) | 6.2 | $25M | 180k | 139.12 | |
| Amarin Corporation (AMRN) | 5.1 | $21M | 963k | 21.44 | |
| Apellis Pharmaceuticals (APLS) | 4.4 | $18M | 587k | 30.62 | |
| Bluebird Bio (BLUE) | 4.4 | $18M | 204k | 87.75 | |
| Zymeworks | 4.4 | $18M | 389k | 45.46 | |
| Myokardia | 4.2 | $17M | 231k | 72.88 | |
| Zogenix | 3.7 | $15M | 287k | 52.13 | |
| Acceleron Pharma | 3.5 | $14M | 268k | 53.02 | |
| Sage Therapeutics (SAGE) | 3.4 | $14M | 190k | 72.19 | |
| Axsome Therapeutics (AXSM) | 3.2 | $13M | 125k | 103.36 | |
| Reata Pharmaceuticals Inc Cl A | 2.8 | $11M | 56k | 204.43 | |
| Biohaven Pharmaceutical Holding | 2.5 | $10M | 187k | 54.44 | |
| Rts/bristol-myers Squibb Compa | 2.5 | $10M | 3.3M | 3.01 | |
| Uniqure Nv (QURE) | 2.5 | $9.9M | 138k | 71.66 | |
| Chemocentryx | 1.8 | $7.4M | 186k | 39.55 | |
| Kadmon Hldgs | 1.5 | $6.1M | 1.4M | 4.53 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $6.1M | 221k | 27.68 | |
| Springworks Therapeutics (SWTX) | 1.3 | $5.2M | 134k | 38.49 | |
| Rocket Pharmaceuticals (RCKT) | 1.2 | $5.1M | 223k | 22.76 | |
| Molecular Templates | 1.2 | $4.8M | 340k | 13.99 | |
| Constellation Pharmceticls I | 1.2 | $4.8M | 101k | 47.11 | |
| Iveric Bio | 1.1 | $4.5M | 524k | 8.58 | |
| Igm Biosciences (IGMS) | 1.1 | $4.4M | 114k | 38.16 | |
| Assembly Biosciences | 0.9 | $3.8M | 188k | 20.46 | |
| Bellus Health | 0.8 | $3.2M | 425k | 7.60 | |
| Karuna Therapeutics Ord | 0.7 | $3.0M | 40k | 75.34 | |
| Aptose Biosciences | 0.7 | $3.0M | 524k | 5.67 | |
| Mei Pharma | 0.7 | $2.8M | 1.1M | 2.48 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $2.5M | 27k | 91.10 | |
| Savara (SVRA) | 0.6 | $2.5M | 614k | 4.03 | |
| 89bio (ETNB) | 0.6 | $2.3M | 87k | 26.28 | |
| Fulcrum Therapeutics (FULC) | 0.5 | $2.1M | 124k | 16.64 | |
| Minerva Neurosciences | 0.4 | $1.6M | 228k | 7.11 | |
| Ardelyx (ARDX) | 0.4 | $1.6M | 212k | 7.50 | |
| Kezar Life Sciences (KZR) | 0.1 | $493k | 123k | 4.01 | |
| Neoleukin Therapeutics | 0.1 | $499k | 41k | 12.31 |
